Karyopharm Therapeutics
KPTI
#9072
Rank
NZ$0.14 B
Marketcap
$1.15
Share price
-0.72%
Change (1 day)
-4.47%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: NZ$0.14 Billion

As of December 2024 Karyopharm Therapeutics has a market cap of NZ$0.14 Billion. This makes Karyopharm Therapeutics the world's 9072th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.14 B-7.07%
2023NZ$0.15 B-74.16%
2022NZ$0.60 B-14.75%
2021NZ$0.71 B-54.96%
2020NZ$1.57 B-15.14%
2019NZ$1.86 B118.98%
2018NZ$0.84 B33.24%
2017NZ$0.63 B13.95%
2016NZ$0.55 B-19.39%
2015NZ$0.69 B-55.55%
2014NZ$1.56 B89.29%
2013NZ$0.82 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Karyopharm Therapeutics was reported to be:

NZ$0.14 Billion
by Nasdaq info icon info icon
NZ$0.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$442.83 B 304,072.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$206.34 B 141,631.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$344.12 B 236,268.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.24 B 11,743.67%๐Ÿ‡บ๐Ÿ‡ธ USA